5 December 2023
- 18:2818:28, 5 December 2023 diff hist +101 Facility: Library (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2818:28, 5 December 2023 diff hist +101 Foundation: UMCG Volunteers & Friends (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2818:28, 5 December 2023 diff hist +101 Novel Therapies and Diagnostic Methods (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2718:27, 5 December 2023 diff hist +102 Training: Oncology nurse - Comprehensive Cancer Center (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2718:27, 5 December 2023 diff hist +102 Course: Medicine bachelors and masters degree - Comprehensive Cancer Center (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2618:26, 5 December 2023 diff hist +102 Experts (University Medical Center Groningen Comprehensive Cancer Center) No edit summary
- 18:2518:25, 5 December 2023 diff hist +25 University Medical Center Groningen Comprehensive Cancer Center →Trials (University Medical Center Groningen Comprehensive Cancer Center)
- 18:2518:25, 5 December 2023 diff hist +109,322 N Trials (University Medical Center Groningen Comprehensive Cancer Center) Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to University Medical Center Groningen Comprehensive Cancer Center page '''NCTID''': NCT03719690 '''Title''': Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy '''Study Summary''': An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). Th..."
- 18:2318:23, 5 December 2023 diff hist −5 University Medical Center Groningen Comprehensive Cancer Center →Trials
- 18:2118:21, 5 December 2023 diff hist +85 Tool: Cancer Referral Guide (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2118:21, 5 December 2023 diff hist +85 Resource: Toon Hermans Huis Maastricht (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2118:21, 5 December 2023 diff hist +85 Resource: IPSO Centers (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2118:21, 5 December 2023 diff hist +85 Resource: Combined Lifestyle Intervention (GLI) in cancer (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2018:20, 5 December 2023 diff hist +85 Resource: Stop smoking - personal guidance (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2018:20, 5 December 2023 diff hist +85 Resource: Patient Panel (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:2018:20, 5 December 2023 diff hist +85 Foundation: Young and Cancer - AYA (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:1918:19, 5 December 2023 diff hist +85 Novel Therapies and Diagnostic Methods (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:1918:19, 5 December 2023 diff hist +86 Training: GROW - School for Oncology and Reproduction (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:1818:18, 5 December 2023 diff hist +86 Experts (The Maastricht UMC+ Comprehensive Cancer Center) No edit summary
- 18:1818:18, 5 December 2023 diff hist +25 The Maastricht UMC+ Comprehensive Cancer Center →Trials (The Maastricht UMC+ Comprehensive Cancer Center)
- 18:1718:17, 5 December 2023 diff hist +49,268 N Trials (The Maastricht UMC+ Comprehensive Cancer Center) Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to The Maastricht UMC+ Comprehensive Cancer Center page '''NCTID''': NCT02968303 '''Title''': Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy '''Study Summary''': Rationale: The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it takes time till responses occu..."
- 18:1618:16, 5 December 2023 diff hist −5 The Maastricht UMC+ Comprehensive Cancer Center →Trials
- 18:1518:15, 5 December 2023 diff hist +91 Council: The Patient Council of the Netherlands Cancer Institute (PaR) (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1518:15, 5 December 2023 diff hist +91 Facility: AVL Facilities and Services (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1518:15, 5 December 2023 diff hist +91 Facility: Center for Quality of Life (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1518:15, 5 December 2023 diff hist +91 Resource: AYA - Caring for young adults with cancer (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1418:14, 5 December 2023 diff hist +91 Foundation: AVL Patient Care (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1418:14, 5 December 2023 diff hist +91 Novel Therapies and Diagnostic Methods (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1318:13, 5 December 2023 diff hist +92 Course: Experimental Oncology (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1318:13, 5 December 2023 diff hist +94 Training: Medical statistics with R (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1318:13, 5 December 2023 diff hist +92 Training: Oncology Graduate School Amsterdam (OOA) - Training program (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1118:11, 5 December 2023 diff hist +92 Experts (Netherlands Cancer Institute - Antoni van Leeuwenhoek) No edit summary
- 18:1018:10, 5 December 2023 diff hist +25 Netherlands Cancer Institute - Antoni van Leeuwenhoek →Trials (Netherlands Cancer Institute - Antoni van Leeuwenhoek)
- 18:0918:09, 5 December 2023 diff hist +173,377 N Trials (Netherlands Cancer Institute - Antoni van Leeuwenhoek) Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Netherlands Cancer Institute - Antoni van Leeuwenhoek page '''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc...."
- 18:0918:09, 5 December 2023 diff hist −5 Netherlands Cancer Institute - Antoni van Leeuwenhoek →Trials
- 18:0818:08, 5 December 2023 diff hist +73 Quality of Life and Palliative Care Research (The Netherlands) No edit summary
- 18:0818:08, 5 December 2023 diff hist −33 Patient Guides: ESMO Patient Guides Compilation (The Netherlands) No edit summary
- 18:0718:07, 5 December 2023 diff hist −74 Initiative: National Action Plan for Cancer & Life (The Netherlands) No edit summary
- 18:0718:07, 5 December 2023 diff hist −59 Report: EU Country Cancer Profile 2023 (The Netherlands) No edit summary
- 18:0718:07, 5 December 2023 diff hist −60 Report: Breast cancer screening program (The Netherlands) No edit summary
- 18:0718:07, 5 December 2023 diff hist −16 Reports: Palliaweb (The Netherlands) No edit summary
- 18:0718:07, 5 December 2023 diff hist −6 Reports: IKNL (The Netherlands) No edit summary
- 18:0618:06, 5 December 2023 diff hist −58 Guidelines: Guidelines for Palliative Care (The Netherlands) No edit summary
- 18:0618:06, 5 December 2023 diff hist −28 Guidelines: IKNL Guidelines Compilation (The Netherlands) No edit summary
- 18:0518:05, 5 December 2023 diff hist +19 Survey: National Population Surveys: Screenings for breast, cervical and colon cancer (The Netherlands) No edit summary
- 18:0518:05, 5 December 2023 diff hist +18 Database: Registry of Histo and Cytopathology (The Netherlands) No edit summary
- 18:0518:05, 5 December 2023 diff hist +18 Database: Mortality by Cause of Death (The Netherlands) No edit summary
- 18:0518:05, 5 December 2023 diff hist −24 Database: Netherlands Cancer Registry (NKR) (The Netherlands) No edit summary
- 18:0518:05, 5 December 2023 diff hist +18 Database: Netherlands Cancer Registry (NKR) (The Netherlands) No edit summary
- 18:0418:04, 5 December 2023 diff hist +19 Database: National Basic Register of Hospital Care (LBZ) (The Netherlands) No edit summary
